Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

The Evolving Terrain of Predictive Genomics

NextEdge Admin

06 Dec 2023

4 min 23 sec

The landscape of predictive genomics is dynamic, and ongoing research and technological advancements continue to shape its trajectory

Genomic Data and Sequencing Technology:

Advances in DNA sequencing technologies have significantly reduced the cost of genome sequencing.
Large-scale genomic databases, such as the Human Genome Project, 1000 Genomes Project, and initiatives like the All of Us Research Program in the United States, have contributed to a wealth of genomic data.

Polygenic Risk Scores (PRS):

Polygenic risk scores have gained attention as a way to predict an individual’s risk for certain diseases based on the cumulative effect of multiple genetic variants.
PRS is being studied for various conditions, including cardiovascular diseases, cancer, and neurodegenerative disorders.

Machine Learning and AI in Genomics:

Machine learning and artificial intelligence (AI) are increasingly being applied to analyze vast genomic datasets.
These techniques help in identifying patterns, associations, and predictive models that may not be apparent through traditional methods.

Cancer Genomics:

Predictive genomics is extensively used in cancer research to identify genetic mutations associated with specific types of cancer.
Targeted therapies and personalized treatment plans based on the genomic profile of tumors are becoming more common.

Pharmacogenomics:

Pharmacogenomics involves studying how an individual’s genetic makeup influences their response to drugs.
Genetic testing for drug metabolism is becoming more prevalent to guide medication selection and dosing.

Population-Scale Genomic Initiatives:

Countries and organizations around the world are investing in large-scale genomic initiatives to understand the genetic basis of diseases and improve healthcare.
The UK Biobank is one such initiative providing valuable insights into the relationship between genetics and health.

Ethical and Privacy Considerations:

The increasing availability of genomic data raises important ethical and privacy considerations.
Discussions around consent, data sharing, and protecting individual privacy are essential components of the evolving landscape.

Integration with Electronic Health Records (EHR):

Efforts are being made to integrate genomic information with electronic health records to create a more comprehensive view of an individual’s health profile.
This integration facilitates more personalized and timely healthcare interventions.

Patient Empowerment and Education:

There is a growing emphasis on educating individuals about their genomic information, its implications, and the role of genetics in health.
Direct-to-consumer genetic testing has become more accessible, allowing individuals to explore their genetic makeup and potential health risks.

International Collaboration:

Collaborative efforts between researchers, institutions, and countries are crucial for advancing predictive genomics on a global scale.
Sharing data and findings can accelerate progress and improve the understanding of the genetic basis of diseases.

Related Tags

potential health risks

Predictive Genomics

Personalized Cancer Immunotherapy: Understanding Neoantigen Vaccines

Illumina Teams Up with Janssen R&D to Propel Development of MRD Liquid Biopsy Test for Oncology Research

Top Reviews

No reviews yet

The Evolving Terrain of Predictive Genomics

NextEdge Admin

06 Dec 2023

4 min 23 sec

The landscape of predictive genomics is dynamic, and ongoing research and technological advancements continue to shape its trajectory

Genomic Data and Sequencing Technology:

Advances in DNA sequencing technologies have significantly reduced the cost of genome sequencing.
Large-scale genomic databases, such as the Human Genome Project, 1000 Genomes Project, and initiatives like the All of Us Research Program in the United States, have contributed to a wealth of genomic data.

Polygenic Risk Scores (PRS):

Polygenic risk scores have gained attention as a way to predict an individual’s risk for certain diseases based on the cumulative effect of multiple genetic variants.
PRS is being studied for various conditions, including cardiovascular diseases, cancer, and neurodegenerative disorders.

Machine Learning and AI in Genomics:

Machine learning and artificial intelligence (AI) are increasingly being applied to analyze vast genomic datasets.
These techniques help in identifying patterns, associations, and predictive models that may not be apparent through traditional methods.

Cancer Genomics:

Predictive genomics is extensively used in cancer research to identify genetic mutations associated with specific types of cancer.
Targeted therapies and personalized treatment plans based on the genomic profile of tumors are becoming more common.

Pharmacogenomics:

Pharmacogenomics involves studying how an individual’s genetic makeup influences their response to drugs.
Genetic testing for drug metabolism is becoming more prevalent to guide medication selection and dosing.

Population-Scale Genomic Initiatives:

Countries and organizations around the world are investing in large-scale genomic initiatives to understand the genetic basis of diseases and improve healthcare.
The UK Biobank is one such initiative providing valuable insights into the relationship between genetics and health.

Ethical and Privacy Considerations:

The increasing availability of genomic data raises important ethical and privacy considerations.
Discussions around consent, data sharing, and protecting individual privacy are essential components of the evolving landscape.

Integration with Electronic Health Records (EHR):

Efforts are being made to integrate genomic information with electronic health records to create a more comprehensive view of an individual’s health profile.
This integration facilitates more personalized and timely healthcare interventions.

Patient Empowerment and Education:

There is a growing emphasis on educating individuals about their genomic information, its implications, and the role of genetics in health.
Direct-to-consumer genetic testing has become more accessible, allowing individuals to explore their genetic makeup and potential health risks.

International Collaboration:

Collaborative efforts between researchers, institutions, and countries are crucial for advancing predictive genomics on a global scale.
Sharing data and findings can accelerate progress and improve the understanding of the genetic basis of diseases.